A perspective on potential antibody-dependent enhancement of SARS-CoV-2

2020/07/13 by Ann M. Arvin, Katja Fink, Michael Schmid +9 · 2 citations
Medicine · #Antibody #Antibody-dependent enhancement #COVID-19 Clinical Research Studies #Coronavirus #Coronavirus disease 2019 (COVID-19) #Disease #Immune system #Immunity #Immunology #Immunopathology #Infectious disease (medical specialty) #Medicine #Pandemic #SARS-CoV-2 and COVID-19 Research #SARS-CoV-2 detection and testing #Vaccination #Viral replication #Virology #Virus

paper · pdf · doi:10.1038/s41586-020-2538-8

crossref issued 2020/07/13 · crossref published 2020/07/13 · crossref published-online 2020/07/13 · openalex publication_date 2020/07/13 · crossref created 2020/07/13 · crossref published-print 2020/08/20 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/14 · openalex updated_date 2026/07/29

Citations

• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
• Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
• Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
• Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Cited by

• Prospects for a safe COVID-19 vaccine
• COVID-19 vaccine misinformation and hesitancy [wikipedia]